Rob Roscow

Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications. This is the first step in the process of receiving a patent, which needs to be granted by an overseeing body. Mydecine's Patent On The MYCO-006 Family Of Compounds...

Mydecine Innovations Group (OTC: MYCOF), a Denver-based psychedelics research company, announced its four lead novel drug candidates on Wednesday. The company plans to present the candidates at Pre-Investigational New Drug meetings with the FDA and Health Canada, a necessary step in obtaining...